Portal Hypertension and Ascites in Extramedullary Hematopoiesis

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Myeloproliferative diseases (MPD) are clonal stem cell disorders which mainly include polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF). They are characterized by leucocytosis, thrombocytosis, erythrocytosis, splenomegaly, and bone marrow hypercellularity. This might also result in extramedullary hematopoiesis. Abdominal manifestation has been recognized as a feature of these disorders. Splenomegaly and hepatomegaly are fairly common as opposed to ascites which is rare. The MPDs mainly affect the hepatic circulatory systems. The common hepatic manifestations are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), and nodular regenerative hyperplasia.A few other features seen in MPDs are caused by extramedullary hematopoiesis, increased hepatic blood flow, and secondary hemosiderosis from multiple blood transfusions. Portal hypertension is found in up to 7% of patients. We report a case of portal hypertension with ascites in a patient with extramedullary hematopoiesis treated with transjugular intrahepatic portocaval shunt (TIPS). © 2012 INASL.

Cite

CITATION STYLE

APA

Amarapurkar, P., Parekh, S., Amarapurkar, A., & Amarapurkar, D. (2012). Portal Hypertension and Ascites in Extramedullary Hematopoiesis. Journal of Clinical and Experimental Hepatology, 2(2), 188–190. https://doi.org/10.1016/S0973-6883(12)60107-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free